Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 8/20 | 0.87 |
| ▸ | PGR | P06401 | 5/20 | 0.87 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.87 |
| ▸ | USP2 | O75604 | 3/20 | 0.87 |
| ▸ | MEN1 | O00255 | 1/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.87 |
| ▸ | LMNA | P02545 | 3/20 | 0.87 |
| ▸ | MAPT | P10636 | 3/20 | 0.87 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.87 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.87 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.87 |
| ▸ | MLNR | O43193 | 1/20 | 0.87 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.87 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.87 |
| ▸ | PPARG | P37231 | 1/20 | 0.87 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.87 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.87 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.73 |
| ▸ | DRD2 | P14416 | 1/20 | 0.73 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11580237 | 1.00 | NR3C1 (0.87) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL11580241 | 1.00 | NR3C1 (0.87) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL11582001 | 0.98 | NR3C1 (0.84) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL11582000 | 0.98 | NR3C1 (0.83) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL11580239 | 0.96 | NR3C1 (0.88) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL565893 | 0.96 | NR3C1 (0.88) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL11580246 | 0.96 | NR3C1 (0.88) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL596943 | 0.96 | NR3C1 (0.88) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL10857890 | 0.94 | NR3C1 (0.82) | NR3C1PGRCYP3A4USP2MEN1 | |
| SCHEMBL10857885 | 0.94 | NR3C1 (0.82) | NR3C1PGRCYP3A4USP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2680 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117500823-A | Chimeric proteins in autoimmunity | 沙塔克实验室有限公司 | 2024-02-02 | — | — | CN | claimed |
| EP-4305051-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | Shattuck Labs, Inc. (US) | 2024-01-17 | — | — | EP | claimed |
| US-20230192771-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2023-06-22 | — | — | US | claimed |
| WO-2023077152-A2 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| EP-4021944-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | Shattuck Labs, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| US-20210277064-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2021-09-09 | — | — | US | claimed |
| EP-3840769-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | Bacainn Biotherapeutics, Ltd. (KY) | 2021-06-30 | — | — | EP | claimed |
| CN-112888452-A | Cyclosporin compositions and methods of use | 贝凯恩生物医疗技术有限公司 | 2021-06-01 | — | — | CN | claimed |
| WO-2021041958-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS. INC. (US) | 2021-03-04 | — | — | WO | claimed |
| WO-2020123806-A1 | MODULATION OF PD-1 | Beth Israel Deaconess Medical Center. Inc. (US) | 2020-06-18 | — | — | WO | claimed |
| WO-2004071469-A2 | METHODS OF ADMINISTERING A DERMATOLOGICAL AGENT TO A SUBJECT | TEIKOKU PHARMA USA, INC. (US) | 2004-08-26 | — | — | WO | claimed |
| EP-0614354-B1 | USE OF SALICYLIC ACID FOR REGULATING SKIN ATROPHY | RICHARDSON VICKS INC (US) | 2001-01-17 | — | — | EP | claimed |
| US-5804572-A | APPLYING SALICYLIC ACID, AND AN ANTIINFLAMMTORY AGENT WITH A CARRIER | THE PROCTER & GAMBLE COMPANY (US) | 1998-09-08 | — | — | US | claimed |
| US-5756487-A | Use of salicyclic acid for regulating skin wrinkles and or skin atrophy | RICHARDSON-VICKS INC. (US) | 1998-05-26 | — | — | US | claimed |
| US-5605894-A | A MIXTURE OF SALICYLIC ACID, A SUNSCEEN, ANTIINFLAMMATORY AGENT, VITAMIN, ANTIOXIDANT, CHELATOR, RETINOID, A BENZUFURAN, AN N-ACETYL-L-CYSTEINE AND A SKIN PROTECTANT; NONTOXIC | RICHARDSON-VICKS INC. (US) | 1997-02-25 | — | — | US | claimed |
| US-5597813-A | COMPOSITION INCLUDES AN ANTIINFLAMMATORY AGENT | RICHARDSON-VICKS INC. (US) | 1997-01-28 | — | — | US | claimed |
| EP-0614353-A1 | COMPOSITIONS FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1994-09-14 | — | — | EP | claimed |
| EP-0614354-A1 | USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1994-09-14 | — | — | EP | claimed |
| WO-1993010755-A1 | COMPOSITIONS FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| WO-1993010756-A1 | USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1993-06-10 | — | — | WO | claimed |